ArticleHematological oncology2025

Efficacy of Axicabtagene Ciloleucel Compared to Historical Treatments for Relapsed/Refractory Diffuse Large B-Cell Lymphoma of Asian Descent: A Matching Adjusted Indirect Comparison of ZUMA-1 vs REAL-TREND.

Frederick L Locke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.